A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression
Clinical trial NCT02300987 · COMPLETED
Trial details
- NCT number
- NCT02300987
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-26
- Primary completion
- 2018-02-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.